Beijing FDA To Start Safety Blacklist Scheme In April
This article was originally published in PharmAsia News
Executive Summary
Beijing FDA will implement a pharma safety blacklist scheme beginning April 1, under which the authority will list on its Website drug and device manufacturers in violation of pharma/device regulations.